NASDAQ Volatile Stocks: Plug Power Inc (NASDAQ:PLUG), Wave Systems (NASDAQ:WAVX), Ariad Pharmaceuticals (NASDAQ:ARIA), Galena Biopharma (NASDAQ:GALE)

Finally, Zacks upgraded shares of Plug Power Inc (NASDAQ:PLUG) from a neutral rating to an outperform rating. Zacks now has a $7.90 price target on that stock. Plug Power Inc (NASDAQ:PLUG) stock performance was -4.51% in last session and finished the day at $6.99. Traded volume was 23.45million shares in the last session and the average volume of the stock remained 44.53million shares. The beta … Continue reading NASDAQ Volatile Stocks: Plug Power Inc (NASDAQ:PLUG), Wave Systems (NASDAQ:WAVX), Ariad Pharmaceuticals (NASDAQ:ARIA), Galena Biopharma (NASDAQ:GALE)

NASDAQ Losers: Gogo Inc (NASDAQ:GOGO), Galena Biopharma Inc (NASDAQ:GALE), Idera Pharmaceuticals (NASDAQ:IDRA), Peregrine Pharmaceuticals (NASDAQ:PPHM)

Gogo Inc (NASDAQ:GOGO) was the recipient of a large growth in short interest in January. As of March 31st, there was short interest totalling 10,866,166 shares, a growth of 22.4% from the March 14th total of 8,875,654 shares. Gogo Inc (NASDAQ:GOGO) stock performance was -7.70% in last session and finished the day at $16.79. Traded volume was 5.92million shares in the last session and the average … Continue reading NASDAQ Losers: Gogo Inc (NASDAQ:GOGO), Galena Biopharma Inc (NASDAQ:GALE), Idera Pharmaceuticals (NASDAQ:IDRA), Peregrine Pharmaceuticals (NASDAQ:PPHM)

Trade-Ideas LLC identified Galena Biopharma Inc (NASDAQ:GALE) as a “dead cat bounce” (down big yesterday but up big today) candidate. TheStreet Quant Ratings rates Galena Biopharma Inc (NASDAQ:GALE) as a sell. Galena Biopharma Inc (NASDAQ:GALE) stock performance was 12.61% in last session and finished the day at $2.50. Traded volume was 6.16million shares in the last session and the average volume of the stock remained … Continue reading Healthcare active runners: Galena Biopharma Inc (NASDAQ:GALE), Bristol-Myers Squibb (NYSE:BMY), Idera Pharmaceuticals Inc (NASDAQ:IDRA), EXACT Sciences Corporation (NASDAQ:EXAS)

Neuralstem, Inc. (NYSEMKT:CUR) announced that a study published in the peer-reviewed journal, PLOS ONE, showed that ischemic-stroke rats transplanted with Neuralstem Inc. (NYSEMKT:CUR)’s NSI-566 stem cells in the brain experienced functional improvements. Neuralstem, Inc. (NYSEMKT:CUR) stock performance was 3.74% in last session and finished the day at $3.88. Traded volume was 2.54million shares in the last session and the average volume of the stock remained … Continue reading Biotech Most Volatile: Neuralstem (NYSEMKT:CUR), Aegerion Pharmaceuticals (NASDAQ:AEGR), Galena Biopharma Inc (NASDAQ:GALE), Geron Corporation (NASDAQ:GERN)

Achillion Pharmaceuticals Inc (NASDAQ:ACHN) was upgraded by investment analysts at Maxim Group from a “hold” rating to a “buy” rating in a note issued to investors on Monday, TheFlyOnTheWall.com reports. The firm currently has a $6.00 price target on the stock. Maxim Group’s target price would suggest a potential upside of 62.16% from the stock’s previous close. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) stock performance was -7.30% … Continue reading Biotech Bearish Stocks: Achillion Pharmaceuticals (NASDAQ:ACHN), Galena Biopharma (NASDAQ:GALE), Insmed Incorporated (NASDAQ:INSM), CytRx Corporation (NASDAQ:CYTR)

Board of Directors of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) adopted an updated annual incentive cash compensation program for its executive officers to be effective beginning with 2014. The description of this program is set forth in Exhibit 99.1 and is incorporated herein by reference. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) stock performance was -6.80% in last session and finished the day at $24.27. Traded volume was 3.59million shares … Continue reading Biotech Losers: ACADIA Pharmaceuticals (NASDAQ:ACAD), Incyte Corporation (NASDAQ:INCY), Galena Biopharma (NASDAQ:GALE), Alexion Pharmaceuticals (NASDAQ:ALXN)